Jiangsu Lianhuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Jiangsu Lianhuan Pharmaceutical Co Ltd cash flow reinvestment rate. Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Cash Flow Reinvestment Rate of 0.77x as of September 2024, reinvesting CN¥39.75 Million (capex CN¥19.88 Million plus investments CN¥-19.87 Million) from operating cash flow of CN¥51.50 Million. See 600513 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Cash flow reinvestment rate of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. Historical reinvestment intensity for Jiangsu Lianhuan Pharmaceutical Co Ltd across 20 annual periods. Explore 600513 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Jiangsu Lianhuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2002–2024)
Jiangsu Lianhuan Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2002 to 2024. Year-by-year capital reinvestment analysis for Jiangsu Lianhuan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 17.17x | CN¥184.85 Million | CN¥10.77 Million | CN¥184.84 Million | ▲ +1217.5% |
| 2023 | 1.30x | CN¥209.42 Million | CN¥160.70 Million | CN¥200.66 Million | ▼ -61.3% |
| 2022 | 3.37x | CN¥429.70 Million | CN¥127.59 Million | CN¥209.02 Million | ▲ +175.7% |
| 2021 | 1.22x | CN¥168.98 Million | CN¥138.34 Million | CN¥168.92 Million | ▼ -35.6% |
| 2020 | 1.90x | CN¥174.25 Million | CN¥91.94 Million | CN¥174.18 Million | ▼ -92.5% |
| 2017 | 25.42x | CN¥92.44 Million | CN¥3.64 Million | CN¥48.64 Million | ▲ +1876.3% |
| 2016 | 1.29x | CN¥90.42 Million | CN¥70.28 Million | CN¥46.21 Million | ▲ +180.9% |
| 2015 | 0.46x | CN¥28.45 Million | CN¥62.12 Million | CN¥27.41 Million | ▲ +36.2% |
| 2014 | 0.34x | CN¥23.37 Million | CN¥69.50 Million | CN¥23.37 Million | ▼ -59.5% |
| 2013 | 0.83x | CN¥30.85 Million | CN¥37.17 Million | CN¥30.85 Million | ▲ +123.3% |
| 2012 | 0.37x | CN¥6.30 Million | CN¥16.94 Million | CN¥6.30 Million | ▼ -53.0% |
| 2011 | 0.79x | CN¥18.98 Million | CN¥24.00 Million | CN¥18.98 Million | ▼ -35.0% |
| 2010 | 1.22x | CN¥10.26 Million | CN¥8.43 Million | CN¥10.26 Million | ▲ +26.8% |
| 2009 | 0.96x | CN¥13.29 Million | CN¥13.83 Million | CN¥13.29 Million | ▼ -44.6% |
| 2008 | 1.73x | CN¥30.25 Million | CN¥17.44 Million | CN¥30.25 Million | ▼ -1.0% |
| 2007 | 1.75x | CN¥14.08 Million | CN¥8.03 Million | CN¥14.08 Million | ▼ -49.5% |
| 2006 | 3.47x | CN¥35.19 Million | CN¥10.14 Million | CN¥35.19 Million | ▲ +4.9% |
| 2005 | 3.31x | CN¥12.65 Million | CN¥3.82 Million | CN¥12.65 Million | ▲ +114.2% |
| 2004 | 1.54x | CN¥5.24 Million | CN¥3.39 Million | CN¥5.24 Million | ▲ +397.1% |
| 2002 | 0.31x | CN¥5.97 Million | CN¥19.22 Million | CN¥5.97 Million | — |